Vanderbilt researchers have discovered a nanoparticle released from cells, called a “supermere,” which contains enzymes, proteins and RNA associated with multiple cancers, cardiovascular disease, Alzheimer’s disease and even COVID-19.

Michael Waterman, PhD, former chair of the Department of Biochemistry for 18 years, died Nov. 7

The U.S. Food and Drug Administration granted emergency use authorization (EUA) to the global biopharmaceutical company AstraZeneca for a long-acting antibody combination which  protects against COVID-19, discovered last year at Vanderbilt University Medical Center.

Vanderbilt researchers identified a critical role for IL-1beta signaling in leukemia cells with a certain mutation, suggesting this pathway may be a good target for novel treatments.

Vanderbilt researchers suggest that to reduce treatment-related regret for men with localized prostate cancer, treatment preparation should focus on shared decision-making and aligning patient expectations with treatment toxicity.

Three nurses at Vanderbilt University Medical Center have been selected in the inaugural group of Preceptor of the Year Awards by Vanderbilt University School of Nursing.

“VUMC Remembers,” a special virtual memorial service to remember patients who have died as well as their families and caregivers, is now posted at vumcremembers.com.